Ureteral Diseases clinical trials at UCLA
1 research study open to eligible people
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
open to eligible people ages 21-80
A prospective, multi-center, non-randomized trial to demonstrate safety and device performance of the ADVA-Tec Uriprene® Degradable Temporary Ureteral Stent.
Los Angeles, California and other locations
Our lead scientists for Ureteral Diseases research studies include Matthew Dunn, MD.